Vuong Trieu
Chief Scientific Officer, Sorrento Therapeutics.
Companies
- Oncotelic Therapeutics, Inc.Chief executive officer May 2, 2019 to now1
- Oncotelic Therapeutics, Inc.Chair May 2, 2019 to now1
- Oncotelic Therapeutics, Inc.Board member Sep 8, 2021 to Sep 8, 20212
- Adhera Therapeutics, Inc.Board member Oct 4, 2018 to Oct 4, 20183
- Adhera Therapeutics, Inc.Chair Nov 22, 2016 to Apr 18, 20184
- Sorrento TherapeuticsBoard member Sep 19, 2013 to Oct 31, 20135
- Sorrento TherapeuticsChief Scientific Officer Sep 19, 2013 to Oct 31, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Oncotelic Therapeutics, Inc. OTLC100,996,848 shares6$1.9M at $0.02Jul 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Bought 240,000 shares at $0.04 of Oncotelic Therapeutics, Inc.7
- Jun 24, 2026Bought 115,000 shares at $0.05 of Oncotelic Therapeutics, Inc.8
- Jun 23, 2026Bought 75,000 shares at $0.05 of Oncotelic Therapeutics, Inc.8
- Jun 22, 2026Bought 65,000 shares at $0.05 of Oncotelic Therapeutics, Inc.8
- Jun 17, 2026Bought 239,759 shares at $0.04 of Oncotelic Therapeutics, Inc.9
- Jun 15, 2026Bought 96,000 shares at $0.05 of Oncotelic Therapeutics, Inc.9
- Jul 10, 2025Bought 104,000 shares at $0.01 of Oncotelic Therapeutics, Inc.10
- Jul 9, 2025Bought 1 shares at $0.01 of Oncotelic Therapeutics, Inc.10
- Jul 8, 2025Bought 94,736 shares at $0.01 of Oncotelic Therapeutics, Inc.10
- Jan 31, 2025Bought 63,775 shares at $0.03 of Oncotelic Therapeutics, Inc.11
- Jan 30, 2025Bought 100,003 shares at $0.03 of Oncotelic Therapeutics, Inc.11
- Jan 29, 2025Bought 183,066 shares at $0.03 of Oncotelic Therapeutics, Inc.11
- Nov 22, 2024Bought 298,499 shares at $0.03 of Oncotelic Therapeutics, Inc.12
- Aug 23, 2024Bought 500,000 shares at $0.02 of Oncotelic Therapeutics, Inc.13
- Jun 29, 2023Bought 425,000 shares at $0.02 of Oncotelic Therapeutics, Inc.14
- Jun 28, 2023Bought 75,000 shares at $0.03 of Oncotelic Therapeutics, Inc.14
- Jun 16, 2023Bought 100,000 shares at $0.03 of Oncotelic Therapeutics, Inc.15
- Jun 14, 2023Bought 400,000 shares at $0.03 of Oncotelic Therapeutics, Inc.16
- May 26, 2023Bought 126,888 shares at $0.03 of Oncotelic Therapeutics, Inc.17
- May 2, 2023Bought 100,000 shares at $0.05 of Oncotelic Therapeutics, Inc.18
- Dec 6, 2022Bought 120,000 shares at $0.05 of Oncotelic Therapeutics, Inc.19
- Nov 22, 2022Bought 70,000 shares at $0.08 of Oncotelic Therapeutics, Inc.20
- Sep 26, 2022Bought 20,000 shares at $0.07 of Oncotelic Therapeutics, Inc.21
- Aug 25, 2022Bought 80,000 shares at $0.08 of Oncotelic Therapeutics, Inc.22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAdhera Therapeutics, Inc., Chair
- 5SEC EDGARSorrento Therapeutics, Board member
- 6
- 7SEC EDGARForm 4 filed Jul 2, 2026
- 8SEC EDGARForm 4 filed Jun 24, 2026
- 9SEC EDGARForm 4 filed Jun 17, 2026
- 10SEC EDGARForm 4 filed Jul 10, 2025
- 11SEC EDGARForm 4 filed Jan 31, 2025
- 12SEC EDGARForm 4 filed Nov 26, 2024
- 13SEC EDGARForm 4 filed Aug 27, 2024
- 14SEC EDGARForm 4 filed Jun 30, 2023
- 15SEC EDGARForm 4 filed Jun 20, 2023
- 16SEC EDGARForm 4 filed Jun 16, 2023
- 17SEC EDGARForm 4 filed May 31, 2023
- 18SEC EDGARForm 4 filed May 2, 2023
- 19SEC EDGARForm 4 filed Dec 7, 2022
- 20SEC EDGARForm 4 filed Nov 25, 2022
- 21SEC EDGARForm 4 filed Sep 28, 2022
- 22SEC EDGARForm 4 filed Aug 29, 2022